A Study of Duloxetine in Elderly Generalized Anxiety Disorder

Phase 4 Completed 291 enrolled Eli Lilly and Company

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and efficacy of duloxetine versus placebo in elderly patients suffering from generalized anxiety disorder (GAD).

Timeline

Start: 2010-10
Primary completion: 2012-07
Completion: 2012-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	30 mg	Oral
Subject	Duloxetine	Small molecule	120 mg	Oral

A Study of Duloxetine in Elderly Generalized Anxiety Disorder

Summary

Timeline

Drugs

Indications